Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 06, 2020

SELL
$4.82 - $7.72 $1,446 - $2,316
-300 Closed
0 $0
Q1 2020

Apr 21, 2020

SELL
$3.77 - $11.0 $754 - $2,200
-200 Reduced 40.0%
300 $2,000
Q3 2019

Oct 17, 2019

SELL
$3.93 - $15.35 $786 - $3,070
-200 Reduced 28.57%
500 $2,000
Q4 2018

Feb 04, 2019

SELL
$11.63 - $32.67 $1,163 - $3,267
-100 Reduced 12.5%
700 $13,000
Q2 2018

Oct 05, 2018

SELL
$42.06 - $62.4 $4,206 - $6,240
-100 Reduced 11.11%
800 $36,000
Q1 2018

May 09, 2018

BUY
$50.12 - $67.72 $45,108 - $60,948
900 New
900 $48,000

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0

About Clovis Oncology, Inc.


  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Optimum Investment Advisors Portfolio

Follow Optimum Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optimum Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Optimum Investment Advisors with notifications on news.